Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Olesya A. Kuznetsova
Observed names:
O. A. Kuznetsova,
O. A. Kuznetsovа,
O. Kuznetsova,
O.A. Kuznetsova,
O. A. Kuznetsova,
Olesya Kuznetsova,
О. А. Кузнецова
show all 7
Institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
Observed institutions:
St Petersburg University,
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation,
State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care,
Saint Petersburg State Pediatric Medical University
ORCID:
0000-0001-7753-3081
Observed ORCID:
0000-0001-7753-3081
OpenAlex ID:
A5040037979
Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy
2023
·
Alexandra Kavun
, Egor Veselovsky
, et al.
·
Cancers
·
61
PDF
Anti-EGFR rechallenge compared with standard of care for patients with ctDNA RAS/BRAF wild-type chemorefractory metastatic colorectal cancer: A systematic review and meta-analysis
2026
·
Olesya Kuznetsova
, Elena Battaiotto
, et al.
·
Critical Reviews in Oncology/Hematology
·
11
Prognostic and predictive role of immune microenvironment in colorectal cancer
2024
·
Olesya Kuznetsova
, Mikhail Fedyanin
, et al.
·
World Journal of Gastrointestinal Oncology
·
9
The Role of MSI Testing Methodology and Its Heterogeneity in Predicting Colorectal Cancer Immunotherapy Response
2025
·
Alexandra Lebedeva
, Anastasiia Taraskina
, et al.
·
International Journal of Molecular Sciences
·
6
PDF
Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review
2022
·
Andrei Kachmazov
, Larisa Bolotina
, et al.
·
Frontiers in Oncology
·
6
PDF
Comprehensive molecular profiling in MOTION study
2025
·
Olesya A. Kuznetsova
, Maxim V. Ivanov
, et al.
·
Cancer Genetics
·
3
Evaluation of blood MSI burden dynamics to trace immune checkpoint inhibitor therapy efficacy through the course of treatment
2024
·
Egor Veselovsky
, Alexandra Lebedeva
, et al.
·
Scientific Reports
·
3
Case Report: Progressive disease of BRCA2-mutant colon adenocarcinoma following talazoparib therapy
2023
·
Elizaveta Polyanskaya
, Alexandra Lebedeva
, et al.
·
Frontiers in Oncology
·
3
PDF
Analysis of HERV-K (HML2) Expression in Colorectal Cancer Samples
2026
·
Valentina S. Obrezanenko
, Polina M. Shulga
, et al.
·
Epigenomes
·
2
PDF
Neoadjuvant Immunotherapy With Prolgolimab in Patients With Locally Advanced Microsatellite Instability/Defective Mismatch Repair Colorectal Cancer
2025
·
Olesya Kuznetsova
, Albina Zagidullina
, et al.
·
JCO Precision Oncology
·
2
Interim results of neoadjuvant immunotherapy with prolgolimab in patients with locally advanced MSI / dMMR colorectal cancer
2024
·
A. A. Zagidullina
, O. A. Kuznetsova
, et al.
·
Malignant tumours
·
2
PDF
Precision oncology strategy in cetuximab-resistant ERRFI1-mutant colon cancer: case report of disease progression on afatinib.
2023
·
Olesya Kuznetsova
, Alexandra Lebedeva
, et al.
·
PubMed Central
·
2
PDF
The Influence of the Carbonized Layer at the End Face of the Light-Guide on the Results of Endovenous Laser Ablation of Varicose Veins
2016
·
A. N. Belyaev
, O. A. Kuznetsova
, et al.
·
Journal of Venous Disorders
·
2
Псевдомиксома брюшины
2025
·
А. Е. Калинин
, А. А. Доманский
, et al.
·
Malignant tumours
·
1
PDF
Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive disease
2025
·
Daria Kravchuk
, Alexandra Lebedeva
, et al.
·
Frontiers in Immunology
·
1
PDF
Failure of immune checkpoint inhibitors for microsatellite instability-positive pancreatic adenocarcinoma with atypical pattern of short tandem repeat mutation
2024
·
Anna Babayan
, Evgeny Ledin
, et al.
·
Immunotherapy
·
1
PDF
Evidence blocks for effective presentation of genomic findings at molecular tumor boards: Single institution experience
2024
·
Alexandra Lebedeva
, Olesya Kuznetsova
, et al.
·
Heliyon
·
1
Применение панелей комплексного молекулярного профилирования при опухолях желудочно-кишечного тракта. Обзор литературы и собственные результаты
2023
·
О. А. Кузнецова
, М. Ю. Федянин
, et al.
·
Malignant tumours
·
1
PDF
Comprehensive multigene profiling impact on clinical decisions in patients with advanced cancers: A multicenter, retrospective analysis.
2023
·
Olesya Kuznetsova
, Maxim Ivanov
, et al.
·
Journal of Clinical Oncology
·
1
Personalized therapy in solid tumors: results of a retrospective multicentre study of the clinical applicability of the FoundationOne® Medicine Test
2022
·
M. L. Stepanova
, O. A. Kuznetsovа
, et al.
·
Surgery and Oncology
·
1
PDF
Clinical utility and implementation of a virtual molecular tumor board in real-world oncology practice
2026
·
Olesya Kuznetsova
, Maria Cheporova
, et al.
·
Cancer Genetics
Antitumor mechanisms of acetylsalicylic acid: a review of current evidence
2025
·
O. A. Kuznetsova
, M. S. Manukyan
, et al.
·
Advances in molecular oncology
PDF
74eP Impact of rare KRAS mutations on resectability, conversion, and survival in patients with colorectal cancer liver metastases: A retrospective single-center study
2025
·
G.G. Makiev
, M. Fedyanin
, et al.
·
ESMO Open
PDF
110P Phase II trial of low dose neoadjuvant immunotherapy in locally advanced MSI/dMMR colorectal cancer: First safety and efficacy outcomes
2025
·
A.A. Zagidullina
, O.A. Kuznetsova
, et al.
·
Annals of Oncology
PDF
Validation of high-throughput sequencing-based test system for detection of microsatellite instability in colorectal cancer samples
2025
·
A. A. Lebedeva
, A. N. Taraskina
, et al.
·
Advances in molecular oncology
PDF
Show more works
View as search
Works count:
37
Citation count:
119
H-index:
5
I10-index:
2
Year
Topic
Type